Clinical Trials Logo

Left Ventricular Remodeling clinical trials

View clinical trials related to Left Ventricular Remodeling.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02675322 Completed - Clinical trials for Acute Myocardial Infarction

Danlou Tablets to Prevent Left Ventricular Remodeling

Start date: January 2012
Phase: Phase 4
Study type: Interventional

Danlou tablets are Chinese patent medicine which has been approved in China for the treatment of ischemic heart disease, but the evidence supporting its efficacy on cardiac remodeling remains unclear. This pilot study was designed to determine whether Danlou tablets reduced adverse left ventricular (LV) remodeling in patients with acute myocardial infarction (MI). Patients following acute MI were enrolled and randomly allocated to Danlou tablets (4.5 g q.d. for 90 days) or placebo, superimposed on standard medications for the treatment of MI. Major end points were changes in LV volumes and ejection fractions as evaluated by serial echocardiography in addition to clinical outcomes were also determined.

NCT ID: NCT02305602 Completed - Heart Failure Clinical Trials

A Study of VentriGel in Post-MI Patients

Start date: September 2015
Phase: Phase 1
Study type: Interventional

This Phase I, open label, study will investigate the effects of VentriGel injection in patients who have experienced a first, large ST elevation myocardial infarction (STEMI) treated by PCI within the past 3 years and have evidence of left ventricular remodeling.

NCT ID: NCT01875484 Completed - Clinical trials for Myocardial Infarction

Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling

PMIR-miR-126
Start date: February 2012
Phase: N/A
Study type: Observational

Purpose: The purpose of this study is to evaluate the impact of circulating miR-126 on left ventricular remodeling and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

NCT ID: NCT00469261 Completed - Clinical trials for Myocardial Infarction

Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling

TIPTOP
Start date: May 2007
Phase: Phase 2
Study type: Interventional

The aim of the study is to assess the efficacy of an antibiotic treatment with tetracycline (doxycycline) in the early stage of large reperfused acute myocardial infarction (AMI), in preventing left ventricular (LV) remodeling.